6-[1-[1-(azetidin-3-ylsulfonyl)piperidin-4-yl]pyrazol-4-yl]-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile
C20H23N7O3S — CID 154950959
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[1-[1-(azetidin-3-ylsulfonyl)piperidin-4-yl]pyrazol-4-yl]-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile
6-[1-[1-(azetidin-3-ylsulfonyl)piperidin-4-yl]pyrazol-4-yl]-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile (PubChem CID 154950959) has the molecular formula C20H23N7O3S and a molecular weight of 441.52 g/mol. Its IUPAC name is 6-[1-[1-(azetidin-3-ylsulfonyl)piperidin-4-yl]pyrazol-4-yl]-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile.
Molecular Properties
| Compound Name | 6-[1-[1-(azetidin-3-ylsulfonyl)piperidin-4-yl]pyrazol-4-yl]-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile |
|---|---|
| PubChem CID | 154950959 |
| Molecular Formula | C20H23N7O3S |
| Molecular Weight | 441.52 g/mol |
| Exact Mass | 441.16 |
| IUPAC Name | 6-[1-[1-(azetidin-3-ylsulfonyl)piperidin-4-yl]pyrazol-4-yl]-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile |
| SMILES | COc1cc(-c2cnn(C3CCN(S(=O)(=O)C4CNC4)CC3)c2)cn2ncc(C#N)c12 |
| InChI | InChI=1S/C20H23N7O3S/c1-30-19-6-14(12-27-20(19)15(7-21)8-24-27)16-9-23-26(13-16)17-2-4-25(5-3-17)31(28,29)18-10-22-11-18/h6,8-9,12-13,17-18,22H,2-5,10-11H2,1H3 |
| InChIKey | NZIVFUQLUDMDLQ-UHFFFAOYSA-N |
| XLogP | 1.02 |
| TPSA | 117.55 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 441.52 |
| LogP ≤ 5 | 1.02 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154950959 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.